M&A Deal Summary

Teva Pharmaceutical Industries Acquires Bentley Pharmaceuticals

On March 31, 2008, Teva Pharmaceutical Industries acquired life science company Bentley Pharmaceuticals for 360M USD

Acquisition Highlights
  • This is Teva Pharmaceutical Industries’ 7th transaction in the Life Science sector.
  • This is Teva Pharmaceutical Industries’ 10th largest (disclosed) transaction.
  • This is Teva Pharmaceutical Industries’ 5th transaction in the United States.
  • This is Teva Pharmaceutical Industries’ 1st transaction in New Hampshire.

M&A Deal Summary
Date 2008-03-31
Target Bentley Pharmaceuticals
Sector Life Science
Buyer(s) Teva Pharmaceutical Industries
Deal Type Add-on Acquisition
Deal Value 360M USD

Target

Bentley Pharmaceuticals

Exeter, New Hampshire, United States
Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products. Bentley's proprietary drug delivery technologies enhance the absorption of pharmaceutical compounds across various membranes. Bentley manufactures and markets a growing portfolio of generic and branded generic pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and central nervous system diseases through its subsidiaries -- Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals Ireland. Bentley also manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Teva Pharmaceutical Industries

Tel Aviv, Israel
Category Company
Founded 1901
Sector Life Science
Employees35,001
Revenue 15.8B USD (2023)
DESCRIPTION

Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.

DEAL STATS #
Overall 7 of 23
Sector (Life Science) 7 of 20
Type (Add-on Acquisition) 6 of 19
State (New Hampshire) 1 of 1
Country (United States) 5 of 15
Year (2008) 2 of 3
Size (of disclosed) 10 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-22 CoGenesys

Rockville, Maryland, United States

CoGenesys, Inc. is a biopharmaceutical company with a broad based biotechnology platform and focused on the development of peptide- and protein-based medicines across broad therapeutic categories.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-11-25 Teva Pharmaceutical Industries - Portfolio Of Generic Pharmaceuticals

Israel

The portfolio of products consists of 17 products, including 15 FDA-approved products and 2 development-stage products. Key products in the portfolio include: Cyclosporine Capsules and Liquid,Desmopressin Acetate Tablets,Glipizide/Metformin HCl Tablets , Mirtazapine Orally Disintegrating Tablets,Metoclopramide HCl Tablets.

Sell $36M
Mergr

Product

Company

Legal